Genetic mutations interact intricately to drive the development of skin cancer (e.g., A. PTCH1, CDKN2A, BRAF, TP53, and epigenetic modifications), as well as environmental elements like UV rays, persistent inflammation, and immunosuppression. Here, TP53 is linked to skin cancer.